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ABSTRACT
Objective: To describe the osteoarthritis study population
of CHECK (Cohort Hip and Cohort Knee) in comparison
with relevant selections of the study population of the
Osteoarthritis Initiative (OAI) based on clinical status and
radiographic parameters.
Methods: In The Netherlands a prospective 10-year
follow-up study was initiated by the Dutch Arthritis
Association on participants with early osteoarthritis-
related complaints of hip and/or knee: CHECK. In parallel
in the USA an observational 4-year follow-up study, the
OAI, was started by the National Institutes of Health, on
patients with or at risk of symptomatic knee osteoar-
thritis. For comparison with CHECK, the entire cohort and
a subgroup of individuals excluding those with exclusively
hip pain were compared with relevant subpopulations of
the OAI.
Results: At baseline, CHECK included 1002 participants
with in general similar characteristics as described for the
OAI. However, significantly fewer individuals in CHECK
had radiographic knee osteoarthritis at baseline when
compared with the OAI (p,0.001). In contrast, at
baseline, the CHECK cohort reported higher scores on
pain, stiffness and functional disability (Western Ontario
and McMaster osteoarthritis index) when compared with
the OAI (all p,0.001). These differences were supported
by physical health status in contrast to mental health
(Short Form 36/12) was at baseline significantly worse for
the CHECK participants (p,0.001).
Conclusion: Although both cohorts focus on the early
phase of osteoarthritis, they differ significantly with
respect to structural (radiographic) and clinical (health
status) characteristics, CHECK expectedly representing
participants in an even earlier phase of disease.
Osteoarthritis is the most common diagnosis made
in older patients with knee or hip pain. The
diagnosis can be based on symptoms, signs and
radiographic findings, and as such can be defined
by various sets and combinations of criteria.1 2 The
prognosis of osteoarthritis for the individual
patient is uncertain; the course of symptoms,
clinical signs, disability and radiographic changes
is difficult to predict.3 Besides, it has been demon-
strated that there is inconsistency between the
radiographic change and severity of joint pain with
accompanying disability.4 Clearly, to understand
more about the disease and its course, large
independent detailed observational studies starting
(very) early in the stage of the disease are
necessary.
Therefore, in The Netherlands, a prospective 10-
year follow-up study was recently initiated by the
Dutch Arthritis Association in order to establish
the onset and progression of osteoarthritis in
participants with early complaints of hip and/or
knee pain: CHECK (Cohort Hip and Cohort Knee),
using the International Classification of
Functioning, Disability and Health (ICF) as a
conceptual framework. The ICF model provides
an integrative framework, combining biological,
psychological and social aspects of health and
disease.5 The objective of CHECK is to study the
course of complaints, the mechanisms that cause
joint damage and to identify markers for the
diagnosis and course of joint damage, as well as
to identify prognostic factors that predict and
explain the course of osteoarthritis. In parallel, an
observational study on osteoarthritis was initiated
by the National Institutes of Health: the
Osteoarthritis Initiative (OAI). This 4-year fol-
low-up study will create a public archive of data,
biological samples and joint images to study the
natural history of, and risk factors for, the onset
and progression of knee osteoarthritis. In fact, both
initiatives, CHECK and the OAI, seek answers to
the same questions in comparable populations. In
the present report the CHECK population is
described at baseline and compared with relevant
subpopulations of the OAI to provide a basis for
further research and a comparison of both cohorts
in the future.
METHODS
CHECK cohort
Design
From October 2002 to September 2005 a cohort
was formed of 1002 participants with pain and/or
stiffness of the knee and/or hip, which is to be
followed prospectively for a period of at least
10 years. Nationwide, 10 general and academic
hospitals in The Netherlands are participating,
located in urbanised and semi-urbanised regions.
The study was approved by the medical ethics
committees of all participating centres, and all
participants gave their written informed consent
before entering the study.
Study population
General practitioners (GP) in the surroundings of
the participating centres were invited to refer
eligible persons to these centres. All patients that
visited the GP on their own initiative, potentially
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fulfilling the inclusion criteria, were referred to one of the 10
participating centres. In addition, participants were recruited
through advertisements and articles in local newspapers and on
the Dutch Arthritis Association website. The physicians in the
participating centres checked whether referred patients as well
as patients from their outpatient clinics fulfilled the inclusion
criteria.
Inclusion criteria
Individuals were eligible if they had pain and/or stiffness of the
knee and/or hip, were aged 45–65 years, and had never or not
longer than 6 months ago visited the GP for these symptoms for
the first time.
Exclusion criteria were: any other pathological condition that
could explain the existing complaints (eg, other rheumatic
disease, previous hip or knee joint replacement, congenital
dysplasia, osteochondritis dissecans, intra-articular fractures,
septic arthritis, Perthes’ disease, ligament or meniscus damage,
plicasyndrome, Baker’s cyst) or co-morbidity that did not allow
physical evaluation and/or follow-up of at least 10 years,
malignancy in the past 5 years and inability to understand the
Dutch language.
Baseline measurements
Variables categorised according to the ICF model (table 1).
Body function and structures: articular and kinesiological factors
To assess cartilage and bone at baseline, imaging techniques
were employed and samples of blood and urine collected.
During follow-up this is also done at 2, 5, and 10 years. At
baseline both knees and hips were analysed in all participants,
independent of symptoms and signs.
Radiographs of the tibiofemoral joints (TFJ) were made by a
weight-bearing posteroanterior (PA) view, semi-flexed (7–10u)
according to Buckland-Wright and colleagues.6–8 Radiographs of
the patellofemoral joints were made by a single standing
mediolateral view in 30u flexion and a skyline (inferior superior)
view in 30u flexion.9 10 For the hip, weight-bearing antero-
posterior (AP) radiographs of the pelvis were made.11 12 In
addition, a weight-bearing single faux profile radiograph of both
hips was obtained.13
All radiographs were made without fluoroscopy, and were
digitalised and centrally stored. Radiographs of PA TFJ and AP
pelvic views at baseline were scored according to Kellgren and
Lawrence (K&L).14 Blood and urine samples were collected,
using a standardised protocol at all sites. Multiple aliquots of
serum, plasma and urine were centrally stored at 280uC. DNA
was collected at baseline and was stored at 220uC.
Kinesiological factors (table 1) were assessed each year by a
protocol that was established to measure clinical features of
knee, hip, and hands.
Body function and structures: pain, stiffness, and fatigue
Questionnaires were selected based on the following criteria:
validated in participants with osteoarthritis; demonstrated
reliability, validity and, if applicable, responsiveness; the
questionnaire is internationally accepted, is available in the
Dutch language and has a high feasibility. Questionnaires are
administered annually.
The Western Ontario and McMaster osteoarthritis index
(WOMAC),15–17 a questionnaire with well-known and good
clinimetric properties and recommended by OMERACT is
utilised to measure pain (five items), stiffness (two items) and
physical functioning (see below).18 19 The five point Likert
version of the WOMAC was used; item responses range from
‘‘none’’ to ‘‘extreme’’ and are summed to produce subscales
(pain 0–20, stiffness 0–8, functioning 0–68) with higher scores
indicating worse health.
Fatigue was assessed with the vitality subscale of the Short
Form 36-item health status survey questionnaire (SF-36). This
questionnaire is a generic instrument yielding scores on eight
scales, with two summary scores, the physical component
summary (PCS) and the mental component summary (MCS).
The physical functioning, role limitations due to physical health
and bodily pain scale contributes most to the scoring of the PCS.
The mental health, role limitations due to emotional problems
and social functioning scales contributes most to the MCS.
These summary scores of the SF-36 are equivalent to the
summary scores of the SF-12,20 as used in the OAI. Scores on the
scales range from 0 to 100, with a higher score indicating a
better health-related quality of life.21
Activities
The WOMAC was used to assess physical functioning (17
items).18 19
Participation
To assess the involvement in life situation, employment and
leisure activities were measured with the questionnaire from the
Patient Panel Chronic Diseases (The Netherlands Institute for
Health Services Research; NIVEL) and the questionnaire
‘‘economic aspects in rheumatoid arthritis’’.22
Environmental factors and personal factors
Table 1 provides an overview of the environmental and personal
factors collected at baseline. Co-morbidity was assessed with a
standard consensus-based list.23 Pain-coping behaviour was
measured with the pain coping inventory, assessing both
behavioural and cognitive coping strategies.24 To assess a
person’s distress and fear, a subscale of the SF-36 was used.
Social support was measured with the Dutch ‘‘social support
scale’’.25 Physical load and economic consequences were assessed
with the Dutch musculoskeletal questionnaire and the ques-
tionnaire ‘‘economic aspects in rheumatoid arthritis’’, respec-
tively.22 26
Every 3 months, the 10 institutes were visited by a single
central coordinator to support complete and accurate data
gathering.
Osteoarthritis Initiative
All details of the OAI are available on the internet (http://www.
oai.ucs.edu). In short, individuals were eligible if they had or were
at risk of symptomatic TF knee osteoarthritis and were aged
between 45 and 79 years. Individuals with inflammatory arthritis,
bilateral end-stage knee osteoarthritis, inability to walk and a
contraindication for magnetic resonance imaging were excluded.
Recruitment of 4796 individuals was realised from March 2004 to
May 2006. At baseline the cohort was divided into two
subcohorts, one with symptomatic knee osteoarthritis (defined
as in at least one knee frequent knee symptoms and radiographic
TF knee osteoarthritis, defined as K&L >2; progression cohort)
and a second cohort of 3285 individuals without symptomatic
knee osteoarthritis, selected on the basis of having specific
characteristics that give them an increased risk of developing
symptomatic knee osteoarthritis (incidence cohort). For the
incidence cohort age-specific eligibility criteria were defined.
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Individuals aged 45–49 years were eligible when they had
frequent knee symptoms, or made frequent use of medication
for the treatment of knee symptoms or had infrequent knee
symptoms, and in addition had one or more other eligible risk
factor such as knee injury, knee surgery, overweight, positive
family history, etc. Individuals aged 50–69 years were eligible if
they had frequent knee symptoms, or made frequent use of
medication for the treatment of knee symptoms, or were
overweight, or had two or more of the eligible risk factors.
At baseline materials for the identification of joint imaging,
biomarkers and genetic markers were collected. Also data on the
clinical and joint status of subjects and on risk factors for the
progression and development of knee osteoarthritis were
collected by questionnaires and examination (categorised
according to the dimensions of the ICF model depicted in
table 1).
In the present report baseline CHECK data of the entire cohort
were compared with data of the OAI incidence cohort. To make
the cohorts more comparable, in addition, CHECK participants
with knee problems (excluding those with exclusively hip
problems; n = 829) were compared with participants of the
OAI incidence cohort within the same age range (45–65 years),
Table 1 Assessment of the variables, categorised according to the dimensions of the ICF, comparison of
CHECK and OAI
CHECK OAI
Body function and
structures
Physiological functions of body systems and anatomical part of the body
Articular factors Single PA view TFJ, mediolateral view TFJ, bilateral Bilateral PA view TFJ
skyline view PFJ AP view pelvis
AP pelvis view, faux profil view of hip PA view dominant hand
Kinesiological factors Pain during joint motion of the hip and knee.
Assisted active range of joint motion of the hip and
knee (in degrees) with a goniometer
Knee flexion pain/tenderness
Knee Palpable warmth, refill test, bony tenderness,
crepitus, patellofemoral grinding test
Effusion, bony tenderness, crepitus patellar
tenderness, alignment, medial-lateral laxity
Hip Sign of Thomas NA
Hand DIP and PIP bony enlargements DIP bony enlargements
Pain Pain scale of WOMAC Pain scale WOMAC
Knee/hip pain intensity 0–10 rating scale Knee pain 0–10 rating scale
KOOS knee pain and symptoms
Stiffness Stiffness scale WOMAC Stiffness scale WOMAC
Other joint symptoms Hip pain, stiffness Symptoms of hip, shoulder, elbow, wrist, hand/
finger, ankle, foot/toe
Foot/toe symptoms
Fatigue Vitality scale of the SF-36-item health status survey
questionnaire
NA
Activities Execution of a task or action by an individual
Limitations in activity Functioning scale WOMAC Functioning scale WOMAC
Participation Involvement in life situation
Working status Employment, current and past Employment, current and past
Participants with paid employment were asked
whether they would like to change their working
environment
Work disability due to health problems
Environmental and
personal factors
Complete background of an individual’s life and living situation
Sociodemographic
characteristics
Age, sex, ethnicity, marital status, household
composition
Age, sex, ethnicity, marital status, residency,
income
Height, weight, education Height, weight, education
Utility EuroQol
Quality of life SF-36 SF-12, KOOS quality of life
Co-morbidity List of complaints and diseases Comorbidity index
Psychological factors
Pain coping Pain coping inventory NA
Fear and depression Scale form the SF-36: emotional role—functioning CES-D (depressive symptoms)
Social support Social support scale NA
Physical workload Based on the Dutch Musculoskeletal Questionnaire Frequent knee bending activities
Physical activity during Physical activity, qualitative and quantitative KOOS sport, recreation
leisure Physical activity (PASE)
Limitation of activity due to knee symptoms
Healthcare use Medical consumption, to have and use aids Medication consumption
Lifestyle Tobacco, alcohol use Tobacco, alcohol use
Changes in feeding habits Dietary nutrient intake
AP, anteroposterior; CHECK, Cohort Hip and Cohort Knee; KOOS, Knee Outcomes in Osteoarthritis Survey; NA, not available; OAI,
Osteoarthritis Initiative; PA, posterioranterior; PASE, physical activity scale for the elderly; PFJ, patellofemoral joint; SF-12, Short
Form 12-item medical outcome study; SF-36, Short Form 36-item health status survey questionnaire; TFJ, tibiofemoral joint;
WOMAC, Western Ontario and McMaster osteoarthritis index.
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who had at least frequent or infrequent knee symptoms excluding
those who eg, just had overweight without symptoms and
excluding those who had had previous knee surgery (n = 1578).
Statistical analyses
Baseline characteristics of both cohorts are presented using
descriptive statistics: median and 25th–75th percentiles or
percentages. Differences between groups are analysed using
Mann–Whitney U tests or the x2 test, when appropriate.
RESULTS
More than 75% of participants were selected based on advertise-
ments including the website. The baseline characteristics of the
participants from CHECK and the relevant populations of the
OAI are presented in table 2. With respect to radiological
osteoarthritis (K&L score) and health status there were some
striking differences between the cohorts.
Radiographic joint damage was clearly more notable in the
OAI compared with CHECK (table 2). In fig 1 the percentage of
participants with a knee K&L grade 0–1 and >2 is depicted.
Based on the definition of K&L grade >2, at baseline only 7% of
CHECK participants had radiographic knee osteoarthritis
compared with 40% in the OAI incidence cohort (p,0.001).
Evidence for radiographic hip osteoarthritis was only present in
7% of the participants of CHECK. The significant difference in
knee K&L grade was also clear when the subgroups of both
cohorts were compared (8% and 32%; p,0.001). Even when the
Table 2 Demographic and disease characteristics in CHECK and selections of the OAI
CHECK
OAI incidence
cohort p Value
CHECK knee
subgroup
OAI incidence
subgroup p Value
N 1002 3285 NA 829 1578 NA
Age in years 56 (52–60) 61 (53–69) ,0.001 56 (52–60) 56 (51–61) 0.8
Gender, female 79% 59% ,0.001 80% 64% ,0.001
BMI, kg/m2 26 (23–28) 28 (25–31) ,0.001 26 (24–28) 28 (25–32) ,0.001
Educational level
Primary school 3% 3% 3% 2%
Secondary school 70% 65% 0.1 71% 65% 0.006
High professional education/university 27% 32% 26% 33%
Site of pain
Knee only 41% 37% 50% 43%
Hip only 17% 7% ,0.001 NA NA 0.002
Knee and hip 42% 48% 50% 57%
No hip or knee pain NA 37% NA NA NA NA
Pain intensity (range 0–10) 3 (3–5) 2 (0–3) ,0.001 3 (2–5) 2 (0–4) ,0.001
K&L rating score for knee
Grade 0 68% 14% 65% 19%
Grade 1 25% 46% 27% 50%
Grade 2 6% 16% ,0.001 7% 16% ,0.001
Grade 3 1% 19% 1% 13%
Grade 4 NA 5% NA 2%
K&L rating score for hip
Grade 0 79% NA NA 83% NA NA
Grade 1 15% NA NA 13% NA NA
Grade 2 5% NA NA 4% NA NA
Grade 3 1% NA NA 0% NA NA
WOMAC subscales
Pain (range 0–20) 5 (2–7) 1 (0–3) ,0.001 5 (2–7) 1 (0–3) ,0.001
Stiffness (range 0–8) 3 (2–4) 1 (0–2) ,0.001 3 (2–4) 1 (0–2) ,0.001
Physical function (range 0–68) 14 (7–24) 2 (0–8) ,0.001 14 (7–24) 3 (0–9) ,0.001
Present employment
Paid job/volunteer 53% 70% ,0.001 52% 79% ,0.001
No paid job 47% 30% 48% 21%
SF-36 subscales (range 0–100):
Physical function 80 (65–90) NA NA 75 (65–85) NA NA
Physical role 100 (50–100) NA NA 100 (38–100) NA NA
Bodily pain 67 (57–80) NA NA 67 (57–80) NA NA
Fatigue 65 (55–75) NA NA 65 (55–75) NA NA
Social function 88 (63–100) NA NA 88 (63–100) NA NA
Fear and depression 100 (100–100) NA NA 100 (100–100) NA NA
Mental health 80 (68–88) NA NA 80 (68–88) NA NA
PCS 47 (40–51) 53 (46–56) ,0.001 47 (40–51) 53 (46–56) ,0.001
MCS 55 (50–59) 55 (50–58) 0.4 55 (50–59) 55 (49–58) 0.3
EuroQol utility 0.7 (0.7–0.8) NA NA 0.7 (0.7–0.8) NA NA
Median values with 25th–75th percentiles between brackets and categorical variables as percentages (%) are given.
BMI, body mass index; K&L, Kellgren and Lawrence grade; MCS, mental component scale (in Cohort Hip and Cohort Knee; CHECK both scales calculated without general health
scale); NA, not available/applicable; braces indicates statistical differences between the distribution of a parameters between both cohorts; OAI, Osteoarthritis Initiative; PCS,
physical component scale; SF-36, Short Form 36-item health status survey questionnaire with higher score indicating a better health-related quality of life; WOMAC, Western
Ontario and McMaster Universities osteoarthritis index with higher scores indicating worst health.
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participants with K&L grade 4 were omitted from the
calculations, the difference in severity of radiographic joint
damage between both cohorts remains evidently significant.
This difference in severity of joint damage between both
cohorts was not based on differences in gender (data not
shown).
Despite the limited number of participants with radiographic
knee osteoarthritis in CHECK, 76% of the patients with knee
symptoms could be diagnosed as osteoarthritis according to the
clinical American College of Rheumatology criteria for the
classification of osteoarthritis.1 2 Only a minority of CHECK
participants with hip symptoms (24%) fulfilled the clinical
classification criteria of hip osteoarthritis.
The evident difference in radiographic joint damage between
both cohorts was not accompanied by a similar difference in
pain and physical function. On the contrary, as shown in fig 2,
on each of the WOMAC subscales participants of CHECK
presented with more pain, stiffness and problems in function
than patients in the OAI. This was observed for the whole
cohorts as well as the subgroups of both cohorts (all p,0.001).
Women reported more pain and functional disability than men,
which was almost identical with the OAI (all p,0.05; data not
shown)
The specific difference in physical function, contrasting the
radiographic difference between both cohorts, was underscored
Figure 1 Comparison of radiographic joint damage between Cohort Hip
and Cohort Knee (CHECK) and Osteoarthritis Initiative (OAI) and their
subpopulations at baseline. The bars depict the percentage of knees with
a Kellgren and Lawrence (K&L) score of 0–1 and a K&L score >2. p
Values for statistical comparison are given.
Figure 2 Comparison of the three Western Ontario and McMaster
Universities osteoarthritis index (WOMAC) subscales for pain, stiffness
and functional disability between Cohort Hip and Cohort Knee (CHECK)
and Osteoarthritis Initiative (OAI) and their subpopulations at baseline.
Box whisker plot (median and 25th–75th percentiles) and p values are
given. A higher score indicates more pain, stiffness and problems in
physical functioning.
Figure 3 Comparison of the physical component summary (PCS) scale
and mental component summary (MCS) scale of the Short Form 36-item
health status survey questionnaire (SF-36/12) between Cohort Hip and
Cohort Knee (CHECK) and Osteoarthritis Initiative (OAI) and their
subpopulations at baseline. Box whisker plot (median and 25th–75th
percentiles) and p values are given. A higher score indicates a better
health-related quality of life.
Figure 4 Schematic presentation of the hypothesis as put forward in
the discussion explaining the (apparent) discrepancy between both
cohorts with respect to pain and joint damage. CHECK, Cohort Hip and
Cohort Knee; OAI, Osteoarthritis Initiative.
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by the difference in PCS in contrast to MCS of the SF-36/12
scale (fig 3); CHECK participants scoring less than patients from
the OAI (p.0.001) for the PCS but not for the MCS (not
significant). Also for these scales, in both cohorts women scored
worse compared with men (all p,0.05; data not shown).
DISCUSSION
The CHECK study is the first prospective 10-year follow-up
study of osteoarthritis in an early phase of the disease that
combines biological, psychological and social aspects of osteoar-
thritis. Radiographic knee osteoarthritis was present only in a
small number of the CHECK participants when compared with
the OAI. In contrast, the participants in CHECK had more pain,
more stiffness, more limitations in activities and a worse health
status. The worse clinical health status is supported by the use
of pain medication: At baseline, only 9% of the participants in
OAI had taken any pain medication, whereas this was 46% for
CHECK (data not shown). Other characteristics such as body
mass index or gender appeared not to be explanatory for this
observed characteristic difference between both cohorts (data
not shown). It could be that the difference in radiographic joint
damage between both cohorts is due to differences in
implementation of the K&L grading method. However, grading
of a random sample of the OAI knee radiographs by those who
performed the grading for CHECK excluded this possibility
(data not shown). Although not expected to be explanatory, it
should be kept in mind that radiographs were taken, although
according to standard protocols, in 10 different centres, whereas
in the OAI only four centres are involved. It can not be ruled out
that the social, cultural and healthcare system differences
between the USA and Europe, in particular The Netherlands,
account for (part of) the difference in reported health status.
Also differences in inclusion between both cohorts can not be
ruled out.
The OAI incidence cohort is recognised as an early
osteoarthritis cohort. Taking the radiological findings into
account, we conclude that CHECK was started in an even
earlier phase of the disease compared with the OAI. Although
this is apparently in discordance with the more severe clinical
symptoms, the relation between radiographic damage and
clinical symptoms has never been clear27 and is the subject of
study in both cohorts. Therefore, it is hypothesised that in the
early phase of osteoarthritis pain, stiffness and disability (of still
unknown origin) are prominent and not yet accompanied by
radiographic findings of osteoarthritis (CHECK). In the
subsequent phase (OAI) patients are coping with the pain and
physical disability, leading to a decrease in the report of these
characteristics, while independently (or maybe as a conse-
quence) structural changes, visible on radiographs, develop. In
other words, earlier recruitment of patients may carry more
perceived symptoms of osteoarthritis (as also seen in rheuma-
toid arthritis), while in a later stage coping with a new disease
may ameliorate the symptoms (fig 4). In the final course of the
disease the structural (radiographic) changes progress and lead
to further pain and disability. It should be taken into account
that, in addition, several other factors, as described in the ICF
model, may add to the apparent discrepancy observed between
pain and structural joint damage over time.28 Our hypothesis
can be tested in the future follow-up of patients in both cohorts,
in particular those with the more severe complaints (still)
without radiographic joint damage. If it appears that the
CHECK population with respect to pain and joint damage,
independent of factors such as social background, healthcare
system differences, cultural difference, variance in methodology
etc, follows the OAI population, then our hypothesis may hold
true. Of course other factors, independent of symptoms and
joint damage, need to be evaluated regarding observed
differences between both cohorts, as such giving both cohorts
their surplus value.
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